An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
No abstract available

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Bone Diseases / diagnosis
  • Bone Diseases / epidemiology
  • Bone Diseases / microbiology
  • Bone Diseases / therapy
  • Clinical Laboratory Techniques
  • Disease Outbreaks / prevention & control
  • Drug Resistance, Bacterial
  • Genotype
  • Humans
  • Infection Control
  • Lung Diseases / diagnosis*
  • Lung Diseases / epidemiology
  • Lung Diseases / microbiology
  • Lung Diseases / therapy*
  • Lymphatic Diseases / diagnosis
  • Lymphatic Diseases / epidemiology
  • Lymphatic Diseases / microbiology
  • Lymphatic Diseases / therapy
  • Mycobacterium Infections, Nontuberculous / diagnosis*
  • Mycobacterium Infections, Nontuberculous / epidemiology
  • Mycobacterium Infections, Nontuberculous / therapy*
  • Skin Diseases / diagnosis
  • Skin Diseases / epidemiology
  • Skin Diseases / microbiology
  • Skin Diseases / therapy

Substances

  • Anti-Infective Agents